Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune (ALT) Stock News, Forecasts and Analysis for Dec. 12, 2025: What Investors Are Watching Ahead of Pemvidutide Catalysts

Altimmune, Inc. (NASDAQ: ALT) is back on many biotech watchlists as investors weigh two competing forces: a near-term clinical and regulatory catalyst calendar for pemvidutide (the company’s lead asset) and a capital-raising backdrop that can quickly change the stock’s risk/reward profile. On Friday, Dec. 12, 2025 , ALT shares are trading in a volatility-heavy tape where options flow, analyst targets, and impending data readouts are all influencing sentiment. Below is a detailed, publication-ready look at today’s ALT stock action , the latest company and clinical news , Wall Street forecasts , and the key catalysts and risks that matter most
Broadcom Earnings: AVGO Forecasts $19.1B Revenue as AI Chip Demand Surges—But Margin Concerns Slam the Stock

Broadcom Earnings: AVGO Forecasts $19.1B Revenue as AI Chip Demand Surges—But Margin Concerns Slam the Stock

Broadcom beat Q4 estimates, lifted its dividend, and guided Q1 revenue to $19.1B as AI chip sales accelerate—yet investors sold off on margin and AI payback concerns. Dec. 12, 2025 — Broadcom’s latest earnings were supposed to be a clear win for the AI ​​infrastructure trade: record quarterly revenue, a stronger-than-expected outlook, and a fast-growing pipeline of custom AI chips and networking gear powering hyperscale data centers. Instead, the company’s shares fell sharply on Friday as Wall Street fixed on one uncomfortable detail— profitability may be getting squeezed as AI becomes a bigger piece of the business .Reuters+ 2Investopedia+ 2
Wheaton Precious Metals WPM Stock Surges to Fresh Highs on the Silver Rally: Latest News, Forecasts, and What to Watch on December 12, 2025

Wheaton Precious Metals WPM Stock Surges to Fresh Highs on the Silver Rally: Latest News, Forecasts, and What to Watch on December 12, 2025

Wheaton Precious Metals Corp. (NYSE: WPM; TSX: WPM) is closing out 2025 in the spotlight, as a record-breaking surge in precious metals—especially silver—pushes streaming and royalty names higher. On Friday, December 12, 2025, WPM traded around $117, after touching an intraday high near $120.47—another sign that momentum remains firmly with the sector. Below is a complete, publication-ready rundown of today’s key WPM stock drivers, the latest company developments, and the most current analyst targets and outlooks shaping the narrative heading into 2026. Wheaton Precious Metals stock price today Wheaton Precious Metals traded near $116.96 on December 12, with a $120.47
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Corporation (NASDAQ: GERN) stock is back in focus on December 12, 2025, as investors digest a sweeping restructuring tied to the company’s commercial push for RYTELO (imetelstat) and its longer-term clinical ambitions. The headlines have been loud—one-third of the workforce is set to be cut, analysts are re-checking their models, and the market is weighing a familiar biotech question: is this the start of a leaner turnaround, or a sign that growth has stalled? Geron Corporation+2BioPharma Dive+2 As of the latest reported trading update on Dec. 12, GERN traded around $1.32, down about 5% on the day, after opening
Freeport-McMoRan Stock (FCX) News Today, Forecasts, and Analyst Outlook (Dec. 12, 2025)

Freeport-McMoRan Stock (FCX) News Today, Forecasts, and Analyst Outlook (Dec. 12, 2025)

FCX stock is trading near the upper end of its 2025 range as copper prices push into record territory. Here’s what’s moving Freeport-McMoRan today (Dec. 12, 2025), plus the latest Wall Street price targets, copper forecasts for 2026, and the key risks investors are watching. Dateline: December 12, 2025 Freeport-McMoRan Inc. (NYSE: FCX ) is back in the spotlight on Friday, Dec. 12, 2025 as the copper market’s latest surge collides with company-specific headlines—from the long road to restarting production at Grasberg to fresh waves of securities litigation notices. Around late morning in US trading, FCX hovered near $47.25 ,
Oriental Culture Holding (NASDAQ: OCG) Stock Rebounds After 89% Crash as Company Files $200M ATM Offering — Latest News, Forecasts, and Analysis (Dec. 12, 2025)

Oriental Culture Holding (NASDAQ: OCG) Stock Rebounds After 89% Crash as Company Files $200M ATM Offering — Latest News, Forecasts, and Analysis (Dec. 12, 2025)

Updated: December 12, 2025 Oriental Culture Holding LTD (NASDAQ: OCG ) is back in the spotlight after one of the most violent two-day price swings on US exchanges this week—an abrupt collapse followed by a sharp rebound—coinciding with a fresh SEC filing that outlines a $200 million at-the-market (ATM) offering program . Below is a detailed, publication-ready breakdown of today’s OCG stock action (12/12/2025) , the new filing and what it means , and the forecasts/analysis currently available for investors trying to make sense of the move. OCG stock price today: extreme volatility remains the headline As of 16:48 UTC
12 December 2025
Citigroup Stock (NYSE: C) Today: JPMorgan Upgrade Sparks Fresh Optimism for 2026 as Citi’s Turnaround Hits Key Milestones

Citigroup Stock (NYSE: C) Today: JPMorgan Upgrade Sparks Fresh Optimism for 2026 as Citi’s Turnaround Hits Key Milestones

Citigroup Inc. (NYSE: C) is back in the spotlight on December 12, 2025 , after a major Wall Street upgrade added momentum to a stock that has already posted a standout run this year. Citi shares traded around $111.91 in the latest session (up slightly on the day), near fresh highs after a string of gains. The immediate catalyst is JPMorgan’s upgrade to “Overweight” —a notable vote of confidence in CEO Jane Fraser’s multi-year overhaul. But the bigger story for investors is whether 2026 becomes the year Citi’s improving fundamentals finally closes the valuation gap with rivals. Below is a
12 December 2025
Hycroft Mining (HYMC) Stock News Today: Eric Sprott Adds $5.7M Ahead of Dec. 29 Annual Meeting, Debt-Free Balance Sheet in Focus (Dec. 12, 2025)

Hycroft Mining (HYMC) Stock News Today: Eric Sprott Adds $5.7M Ahead of Dec. 29 Annual Meeting, Debt-Free Balance Sheet in Focus (Dec. 12, 2025)

(SEO): Hycroft Mining Holding Corporation (NASDAQ: HYMC) stock is active on Dec. 12, 2025 after Eric Sprott disclosed new share purchases. Here’s the latest HYMC news, forecasts, and analysis. Published: December 12, 2025Company: Hycroft Mining Holding Corporation (NASDAQ: HYMC) Hycroft Mining Holding Corporation stock (HYMC) is back in the spotlight on December 12, 2025, as fresh filings and market coverage highlight continued buying by major shareholder Eric Sprott, while investors also track the company’s upcoming annual meeting, recent debt elimination, and exploration-and-development catalysts at its Hycroft Mine in Nevada. TradingView+2SEC+2 Below is a detailed, publication-ready breakdown of today’s HYMC stock
12 December 2025
Bristol-Myers Squibb Stock (BMY) News, Forecasts and Analysis for Dec. 12, 2025: Dividend Hike, FDA Updates, and Wall Street’s 2026 Focus

Bristol-Myers Squibb Stock (BMY) News, Forecasts and Analysis for Dec. 12, 2025: Dividend Hike, FDA Updates, and Wall Street’s 2026 Focus

Dec. 12, 2025 — Bristol-Myers Squibb Company (NYSE: BMY ) is back in the spotlight heading into year-end as investors weigh a fresh dividend increase, meaningful regulatory milestones in oncology, and a pipeline that has delivered both high-profile wins and frustrating setbacks in 2025. By mid-day Friday, BMY stock traded around $52.50, up roughly 2.5% , reflecting a market that’s starting to re-price near-term catalysts even as longer-term questions—patent cliffs, trial readouts, and litigation—remain front and center. BMY stock price today: what’s moving the shares on Dec. 12 The most immediate “today” driver is Wall Street sentiment . On Friday,
12 December 2025
Nike Stock (NKE) Today: Analyst Targets Split Ahead of Dec. 18 Earnings as “Win ​​Now” Turnaround Faces Margin, China, and Tariff Tests

Nike Stock (NKE) Today: Analyst Targets Split Ahead of Dec. 18 Earnings as “Win ​​Now” Turnaround Faces Margin, China, and Tariff Tests

Nike stock (NKE) is in focus on Dec. 12, 2025 ahead of Q2 FY2026 earnings. Here’s the latest news, analyst targets, and what to watch next. Nike, Inc. (NYSE: NKE ) is back in the spotlight on Friday, December 12, 2025 , as investors position ahead of the company’s next earnings report and fresh analyst notes land on Wall Street. Shares have been volatile in recent sessions, and Friday’s tape reflects that: Nike traded between $67.34 and $69.13 and was last seen around $67.50 in late afternoon trading, slightly below the prior close. That push-pull—optimism that Nike’s turnaround efforts are
New Gold Inc (NGD) Stock on Dec. 12, 2025: 52-Week High Momentum, Coeur Buyout Terms, Analyst Forecasts, and What’s Next

New Gold Inc (NGD) Stock on Dec. 12, 2025: 52-Week High Momentum, Coeur Buyout Terms, Analyst Forecasts, and What’s Next

New Gold (NGD) is trading near a 52-week high as investors weigh Coeur Mining’s $7B all-stock acquisition, bullish analyst targets, and gold’s rate-cut rally. On Friday, December 12, 2025 , New Gold Inc. (NYSE American: NGD; TSX: NGD) is once again in the spotlight after a sharp multi-week run that has pushed the stock toward its 52-week highs—while the market continues to price in the company’s pending all-stock acquisition by Coeur Mining (NYSE: CDE) . As of the latest available trade data on Dec. 12, NGD was around $8.32 , after trading between roughly $7.99 and $8.90 intraday. But for
Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare, Inc. (NYSE: MOH) stock was trading around $169.53 on Friday, Dec. 12, 2025, after opening near $168.36 and moving between $166.62 and $171.81 during the session, according to consolidated market data. The move caps a notable short-term rebound for a stock that has spent much of 2025 digesting a steep earnings reset tied to medical cost trend pressure—especially in the Affordable Care Act (ACA) Marketplace—alongside rising policy uncertainty heading into 2026. Below is what’s driving Molina Healthcare stock today (Dec. 12, 2025), what the company’s own preliminary 2026 earnings view implies, and what Wall Street forecasts are signaling
12 December 2025
1 695 696 697 698 699 888

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop